|
2025
|
Invention
|
Bicyclic peptide ligands specific for mt1-mmp.
The present invention relates to polypeptides whi... |
|
|
Invention
|
Bicyclic peptide ligands specific for transferrin receptor 1 (tfr1).
The present invention relat... |
|
|
Invention
|
Peptide ligands for binding to mt1-mmp.
A peptide ligand specific for MT1-MMP comprising a polyp... |
|
2024
|
Invention
|
Bicyclic peptide ligands specific for p-selectin.
The present invention relates to polypeptides ... |
|
|
Invention
|
Bicyclic peptide ligands specific for nectin-4. The present invention relates to polypeptides whi... |
|
|
Invention
|
Bicyclic peptide ligands specific for nectin-4.
The present invention relates to polypeptides wh... |
|
|
Invention
|
Bicyclic peptide ligands specific for cd137.
The present invention relates to polypeptides which... |
|
|
Invention
|
Heterotandem bicyclic peptide complex. The present invention relates to a heterotandem bicyclic p... |
|
2023
|
Invention
|
Methods for treating cancer.
The present invention relates to a method of treating cancer in a s... |
|
|
Invention
|
Bicyclic peptide ligands specific for epha2.
The present invention relates to polypeptides which... |
|
|
Invention
|
Bicyclic peptide ligands with detectable moieties and uses thereof.
The present invention provid... |
|
|
Invention
|
Bicyclic peptide ligands specific for mt1-mmp. The present invention relates to polypeptides whic... |
|
2022
|
Invention
|
Multimeric bicyclic peptide ligands. The present invention relates to multimers of polypeptides w... |
|
|
Invention
|
Bicyclic peptide ligand drug conjugates.
The present invention relates to drug conjugates compri... |
|
|
Invention
|
Conjugated oligonucleotides and uses thereof.
Provided herein are oligomeric compounds comprisin... |
|
|
Invention
|
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands ... |
|
|
Invention
|
Bicyclic peptide ligands specific for p-selectin. The present invention relates to polypeptides w... |
|
|
Invention
|
Bicyclic peptide ligands specific for trem2. The present invention relates to polypeptides which ... |
|
|
Invention
|
Methods for treating cancer.
The present invention relates to a method of treating a cancer in a... |
|
|
Invention
|
Anti-infective bicyclic peptide ligands.
The present invention relates to multimers of polypepti... |
|
|
Invention
|
Anti-infective bicyclic peptide ligands.
The present invention relates to polypeptides which are... |
|
2021
|
Invention
|
Bicycle conjugates specific for nectin-4 and uses thereof.
The present invention relates to a Bi... |
|
|
Invention
|
Treatment of diseases characterized by overexpression of erythropoietin-producing hepatocellular ... |
|
|
Invention
|
Bicyclic peptide ligands specific for tslp. The present invention relates to polypeptides which a... |
|
|
Invention
|
Pbp3 binding bicyclic peptide ligands.
The present invention relates to polypeptides which are c... |
|
|
Invention
|
Anti-infective bicyclic peptide conjugates.
The present invention relates to a polypeptides whic... |
|
2020
|
Invention
|
Bicyclic peptide ligands specific for il-17.
The present invention relates to polypeptides which... |
|
|
Invention
|
Phage cyclisation assay.
The present invention relates to a method for determining an extent of ... |
|
|
Invention
|
Pbp binding bicyclic peptide ligands.
The present invention relates to polypeptides which are co... |
|
|
Invention
|
Heterotandem bicyclic peptide complexes.
The present invention relates to heterotandem bicyclic ... |
|
2019
|
Invention
|
Bicyclic peptide ligands specific for pd-l1.
The present invention relates to polypeptides which... |
|
2018
|
Invention
|
Bicyclic peptide ligands specific for epha2. The present invention relates to polypeptides which ... |
